logo-loader
viewNuvo Pharmaceuticals Inc.

Full interview: Nuvo Pharmaceuticals subsidiary announces Takeda’s Cabpirin approved in Japan

Nuvo Pharmaceuticals (TSE: NRI- OTCQX: NRIFF) President and CEO Jesse Ledger joined Steve Darling from Proactive in Vancouver to discuss the company’s Nuvo Ireland announcing  Takeda Pharmaceutical has given notice  Japan's Ministry of Health, Labor and Welfare have approved Cabpirin combination tablets.

Ledger discusses what this means for the company and its revenue going forward. Ledger also told Proactive how the company is dealing with COVID-19 right now and in the future.

Quick facts: Nuvo Pharmaceuticals Inc.

Price: 0.7 CAD

TSX:NRI
Market: TSX
Market Cap: $7.97 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: GlobeX Data begins a social media influencers program for...

GlobeX Data (OTCQB: SWISF- CSE: SWIS) CEO Alain Ghiai joined Steve Darling from Proactive Vancouver with news the company has started a social media influencers program to help get the word out about their cybersecurity products. Ghiai telling Proactive how the program will work and the...

37 minutes ago

2 min read